Although drug administration via therapeutic antibodies has become popular in recent years, they still face challenges in the clinical setting. In addition to the challenge of achieving sufficient levels of expression of these proteins in the human body, there is also the additional issue of achieving adequate levels of supply to deliver these therapeutic antibodies. Failure to achieve the desired pharmacological concentration of these proteins in the human body leads to toxicities that may lead to life-threatening side effects.
Global Recombinant Therapeutic Antibodies and Proteins market expansion is predicted to be driven by rapid breakthroughs in biomedical science and technology to meet unmet medical requirements, as well as various governments sponsoring research and development of these products.
Read More@ https://bit.ly/3E0S9cZ
